PERSPECTA

News from every angle

← Back to headlines

FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says

An official from the Federal Trade Commission (FTC) stated that the agency is monitoring how major pharmaceutical companies are reacting to upcoming patent expirations.

18 Mar, 11:39 — 18 Mar, 11:39
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed9h ago

FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says

Read full article →

Related Stories

EFCC Returns N3.94 Billion Recovered Funds to NNPCL

7m ago

Indian Court Directs Restitution of ₹650 Crore to Homebuyers in SRS Group Money Laundering Case

11m ago

Xponential Fitness Finalizes $17M FTC Settlement

13m ago

The career rise of Bob Iger, from local weatherman to Disney's repeat CEO

14m ago